Analysts' Actions: ARNA, RIMM, C, ANF, SNDK
NEW YORK (TheStreet) -- CHANGE IN RATINGS
Arena Pharmaceuticals (ARNA) downgraded at BMO to Market Perform, BMO Capital said. $10 price target. Valuation call, as the stock is up 170% since early May.
Boeing (BA) upgraded at Oppenheimer to Outperform from Perform, Oppenheimer said. $90 price target. 787 program has begun to find its footing.
Ball (BLL) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $44 price target.
Bancorp of New Jersey (BKJ) upgraded to buy at TheStreet Ratings.
CF Industries (CF) upgraded at Dahlman from Sell to Buy, Dahlman Rose said. Valuation call, based on a $200 price target.
EMCOR Group (EME) downgraded to hold at TheStreet Ratings.
Greif (GEF) downgraded at JP Morgan from Overweight to Neutral JP Morgan said. Company has extensive exposure to Europe. $48 price target.
Heartland Payment (HPY) upgraded at Wells from Neutral to Outperform, Wells Fargo said. $34 price target. Company will likely gain market share and expand margins.
Hubbell (HUB) rated new Buy at KeyBanc with a Buy rating, KeyBanc said. $90 price target. Favorable end market exposure.
Kirby Corp (KEX) downgraded at BofA Merrill to Neutral from Buy, Bank of America Merrill Lynch said. $56 price target. Costs above and synergies beyond reach.
Mosaic (MO) upgraded at Dahlman from Hold to Buy, Dahlman Rose said. Valuation call, based on a $60 price target.
Research in Motion (RIMM) downgraded at Morgan Stanley from Equal-weight to Underweight, Morgan Stanley said. $7 price target. Book value will likely continue to decline.
Sandisk (SNDK) upgraded at Goldman to Buy, Goldman Sachs said. Supply/demand balance should return to normal by the fourth quarter. $45 price target.
Web.Com Group (WWWW) rated new Buy at Citigroup. $23 price target. Margins expansion from acquisition synergies.